Coronavirus Update: Pfizer-BioNTech vaccine’s efficacy fell to 84% over six months, US, Australia grapple with cases surge
Despite the improving market sentiment, thanks to China’s conciliatory remarks and Fed’s reassurance, the latest coronavirus vaccines update and the relentless rise in the virus cases globally offer little reprieve to the markets.
According to data released on Wednesday, the effectiveness of the Pfizer-BioNTech COVID-19 vaccine fell from 96% to 84% over six months,
The preprint study showed that the efficacy “declined gradually” to 83.7% within six months, with an average decrease of about 6% every two months.
On the covid count front, Australia continues to battle the surge in infections, with Sydney reporting 239 new cases on Wednesday vs. 177 recorded a day ago.
Across the Pacific, rising cases have caused Twitter to shut down its offices in San Francisco and New York once again while Disney has reinstated mask mandate in its California and Florida parks.
Related reads
US Treasury yields, S&P 500 Futures portray risk-off mood
Forex Today: Dollar down as Fed is in no rush to taper